Phase II study of mFOLFOX6 with bevacizumab (Bev) in metastatic gastric and esophageal (GE) adenocarcinoma.
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. Li, J. S. Kortmansky, M. Saif, N. A. Fischbach, L. Ravage-Mass, K. Elligers, C. Hahn, M. K. Cohenuram, J. Lacy
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589184047